Market Capitalization (Millions $) |
18 |
Shares
Outstanding (Millions) |
21 |
Employees |
10 |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
-19 |
Cash Flow (TTM) (Millions $) |
-17 |
Capital Exp. (TTM) (Millions $) |
0 |
Onconova Therapeutics Inc
Onconova Therapeutics Inc is a biopharmaceutical company in the United States that specializes in discovering and developing novel therapies to treat cancer. Founded in 1998, the company has its headquarters in Newtown, Pennsylvania.
The company's approach to treating cancer focuses on targeting the cellular pathways that are responsible for the development and progression of the disease. Onconova's core technology platform, called the Rigosertib pathway, is a proprietary small molecule inhibitor that inhibits certain intracellular signaling pathways associated with cancer.
The company's lead drug candidate is called Rigosertib, which is a broad-spectrum inhibitor of several intracellular kinases and has been shown to have potent anti-cancer activity in preclinical and clinical studies. Rigosertib is currently being evaluated in clinical trials for the treatment of various types of cancer, including myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and solid tumors.
Onconova has also developed several other proprietary small molecule inhibitors that target other intracellular pathways involved in cancer, including those involved in DNA repair, tumor growth, and cell cycle regulation.
The company has collaborations with various academic and research institutions to discover and develop new cancer therapies. Onconova has partnerships with the NIH, the University of Texas MD Anderson Cancer Center, and the Institute of Cancer Research in London.
Onconova Therapeutics is publicly traded on the NASDAQ stock exchange under the ticker symbol ONTX. The company has an experienced management team with a track record of success in the pharmaceutical and biotechnology industries.
Company Address: 12 Penns Trail Newtown 18940 PA
Company Phone Number: 759-3680 Stock Exchange / Ticker: NASDAQ ONTX
ONTX is expected to report next financial results on March 29, 2024. |
|
|